Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Clasificación en acciones #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Precio por acción
$0.2219522
Última sincronización: 2025-09-11
Capitalización bursátil
$1.10B
Cambio (1 día)
0.04%
Cambio (1 año)
0.17%
País
CN
Comercio Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Ratio P/S de Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Ratio P/S al August 2026 TTM: 0.16
Según los informes financieros más recientes y el precio de las acciones de Hubei Biocause Pharmaceutical Co., Ltd., el ratio P/S actual (TTM) es 0.16. Al final de 2022, el ratio P/S era 0.31.
Historial del ratio P/S de Hubei Biocause Pharmaceutical Co., Ltd. desde 2000 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.16 -44.32%
2023 0.28 -9.91%
2022 0.31 -4.58%
2021 0.33 -40.28%
2020 0.55 -20.19%
2019 0.69 -22.30%
2018 0.89 32.65%
2017 0.67 -63.11%
2016 1.82 -93.34%
2015 27.32 249.63%
2014 7.81 114.32%
2013 3.65 -23.01%
2012 4.73 38.93%
2011 3.41 -36.39%
2010 5.36 1.98%
2009 5.25 133.47%
2008 2.25 -70.72%
2007 7.69 165.80%
2006 2.89 172.12%
2005 1.06 -63.15%
2004 2.88 -20.44%
2003 3.62 -72.89%
2002 13.37 64.55%
2001 8.12 4.25%
2000 7.79 0.00%
Ratio P/S de empresas similares o competidoras